Discover a potential breakthrough in treating severe liver scarring with a safe and effective therapy, as revealed by a recent Cleveland Clinic-led study.

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

A new approach combining immunotherapy, radiation, and surgery enabled successful liver cancer removal in a high-risk patient ...

Lee, MD, MAS, a hepatologist and liver transplant specialist with Keck Medicine and principal investigator of ... liver (also ...

Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

After 96 weeks, 39% of patients offered a 50-mg dose of efruxifermin showed a clinically meaningful reduction in liver fibrosis, or scarring, without other symptoms of MASH getting worse, compared ...